Brief: Addex Therapeutics: Q1 Net Loss At CHF 5.8 Mln
05/05/2022 06:11
May 5 (Reuters) - ADDEX THERAPEUTICS LTD ADXN.S :
* Q1 NET LOSS -5.8 MILLION CHF
* Q1 DILUTED LOSS PER SHARE 0.15 CHF
* Q1 INCOME AT EUR 244 THOUSAND
Source text for Eikon: ID:nGNE4n4GJT
Further company coverage: ADXN.S
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Addex Therapeutics
See all newsBrief: Addex Spin-Out Neurosterix Completes Phase 1 Clinical Studies Of NTX-253 For Schizophrenia
NASDAQ RESUMED AT 11:29 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:24 AM
Switzerland's Addex Therapeutics Q2 net loss narrows on decline in R&D expenses
Brief: Addex Therapeutics Q2 Operating Income CHF -645 Thousand